Fresh‐frozen plasma transfusion did not reduce 30‐day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study
Adélaïde Doussau; Paul Perez; Maryse Puntous; Joachim Calderon; Michel Jeanne; Christine Germain; Bertrand Rozec; Virginie Rondeau · 2013 · Transfusion
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract (excerpt)
Background During on‐pump cardiac surgery, hemorrhagic complications occur frequently. Fresh‐frozen plasma ( FFP ) is widely transfused to provide coagulation factors. Yet, no randomized clinical trial has demonstrated its benefits on…
Excerpt shown for reference under fair use — read the full paper at the publisher.
Hosted by the publisher — may require access.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
t-Test at the Probe Level: An Alternative Method to Identify Statistically Significant Genes for Microarray Data
Negative / Null Result ReportMeteorological Causes of the Secular Variations in Observed Extreme Precipitation Events for the Conterminous United States
Negative / Null Result ReportThe Next Generation of Sepsis Clinical Trial Designs
Negative / Null Result ReportAnalysis of DNA Methylation in Young People: Limited Evidence for an Association Between Victimization Stress and Epigenetic Variation in Blood
Negative / Null Result ReportStudy preregistration: an early example and analysis.
Negative / Null Result ReportInsights Into LSTM Fully Convolutional Networks for Time Series Classification
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: Crossref · DOI 10.1111/trf.12422
